Status:
COMPLETED
Registry to Collect Health Information Related to Fibrolamellar Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Fibrolamellar Cancer
FLC
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world. This study will involve collecting infor...
Eligibility Criteria
Inclusion
- Age 13 years or older.
- Personal history of histologically proven fibrolamellar carcinoma (clinical or radiographical suspicion of FLC must be confirmed at MSK or an external hospital)
- Participants must have access to electronic devices that meet the following minimum requirements:
- Ability to connect to the internet
- Capability of running modern internet browers (such as Google Chrome, Internet Explorer, Safari, or Mozilla Firefox).
- Participants must have a google account
Exclusion
- Participants residing in the European Union (EU).
Key Trial Info
Start Date :
November 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 10 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04874519
Start Date
November 24 2021
End Date
November 10 2025
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065